How is it different from Wegovy®?

Zepbound® contains tirzepatide and acts on two receptors, GLP-1 and GIP. Wegovy® contains semaglutide and acts on GLP-1 only. Both are FDA-approved for weight management.

How is it different from compounded tirzepatide?

Zepbound® is an FDA-approved brand-name medication. Compounded tirzepatide is prepared in FDA-regulated 503A pharmacies but is not an FDA-approved medication.

Is it always available?

Availability of brand-name medications depends on the manufacturer and can vary. Your provider can discuss other options if it is unavailable.

Treatment

Zepbound^® Injection

Brand-name tirzepatide, FDA-approved for weight management.

$1,168/mo

Start your evaluation

How this treatment works

Zepbound^® is brand-name tirzepatide made by Eli Lilly and FDA-approved to help people who meet certain criteria lose weight and maintain the weight loss. It acts on two receptors, GLP-1 and GIP, to reduce appetite, and is given once a week by injection.

What's included

Medical evaluation with a US-licensed provider
A treatment plan personalized to your health history
Medication shipped to your home in discreet packaging
Syringes, needles, and an injection kit
Medical follow-up throughout the program
The full PesoBUENO^™ program, at no additional cost

Side effects and considerations

Nausea, most common while the dose is being increased
Constipation or diarrhea
Mild fatigue during the first weeks
Occasional stomach discomfort

This list is not exhaustive. Your doctor will review your full medical history during the evaluation.

Questions about this treatment

Treatment subject to medical review. Available only for adults 18+ in states where telehealth is permitted for this medication.

SaludBUENO guarantee
Free, fast shipping
Doctor-led plans & follow-up
No hidden fees

hola@saludbueno.com 877.283.6624 - 877.BUENO24 5224 W. State Road 46, PMB #358, Sanford, FL 32771

The evaluation available on the SaludBUENO website does not by itself establish a provider-patient relationship between the person completing it and SaludBUENO. CareValidate, a network of U.S.-licensed providers that follows protocols designed for patient safety, sets exclusionary criteria to determine whether a person does not qualify for GLPs treatments. The answers you submit determine whether your case is eligible for review. If you qualify, a licensed provider will review your case before any prescription.

All claims and benefits described on this site are based on experiences reported by patients enrolled in programs that include compounded medications and consultations with health professionals. Results may vary and depend on multiple factors, including program adherence and the treating provider's recommendations.

Compounded GLP medications are produced in FDA-regulated 503A pharmacies. Although these facilities are highly regulated, compounded medications are not FDA-approved or evaluated for safety, efficacy, or quality. The decision to use compounded medications is based on the licensed provider's clinical judgment, taking into account the telehealth consultation and the patient's medical history.

We encourage anyone interested in compounded medications to consult with a health professional about the specific risks and benefits. SaludBUENO does not produce compounded medications. The product received may look different from the images shown on this site.